Status:
UNKNOWN
Treatment of Dentin Hypersensitivity Using Different Desensitizing Agents
Lead Sponsor:
Al-Azhar University
Conditions:
Dentin Sensitivity
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Treatment of Dentin Hypersensitivity Using Theobromine , Remin Pro , and Combination of Both Materials
Eligibility Criteria
Inclusion
- Patients that aged 18-50 years.
- Patients in good general health.
- Patients that have accessible teeth demonstrating signs of sensitivity.
Exclusion
- • Any chronic debilitating disease that could influence study outcomes.
- Partial dentures, orthodontic appliances, implants or restorations in a poor state of repair that could influence study outcomes.
- Intolerance or hypersensitivity to the study desensitizing agents or their ingredients.
- Desensitising treatment or tooth bleaching within 8 weeks of screening.
- Daily use of medications that might influence the perception of pain.(
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04340869
Start Date
August 1 2019
End Date
April 1 2022
Last Update
April 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University , Faculty of Dental medicine for Girls
Cairo, Egypt, 11111